WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the 25th Annual JPMorgan Healthcare Conference on January 11, 2007 in San Francisco. President and CEO, Steven Rauscher, will provide an overview of the Company including details on the continued launch of ANTARA(R) 130 mg (fenofibrate) capsules and the third winter season for FACTIVE(R) (gemifloxacin mesylate) tablets. The presentation will begin at 11:30 AM PT (2:30 PM ET) on Thursday and will be webcast through the Company’s website at www.oscient.com. An archive of the webcast will also be available for three months.
